Home Effects of adolescence-onset hypogonadism on metabolism, bone mineral density and quality of life in adulthood
Article
Licensed
Unlicensed Requires Authentication

Effects of adolescence-onset hypogonadism on metabolism, bone mineral density and quality of life in adulthood

  • Friederike I.W. Tam EMAIL logo , Angela Huebner , Lorenz C. Hofbauer and Julia Rohayem
Published/Copyright: April 18, 2015

Abstract

In a cross-sectional study of 54 patients with adolescence-onset hypogonadism (33 females, 21 males; age range: 19–40 years), medical care, quality of life, and health status were assessed. Most patients had received adequate medical care with short cumulative periods of interruption of hormone replacement. The prevalence of the metabolic syndrome was 27% in females and 19% in males. In comparison to the general population, females had both a lower bone mineral density (dual-energy X-ray absorptiometry, Z-score=−0.8, p<0.001) and a higher prevalence of obesity (age 19–29 years: study population 35%, general population 4%). The body fat percentage (dual-energy X-ray absorptiometry) was significantly elevated (age 19–29 years: females Z-score=+1.8, p<0.001, males Z-score=+2.4, p=0.001). Quality of life (SF-36) was normal. Despite adequate treatment, patients with early-onset hypogonadism are prone to develop signs and symptoms consistent with inadequate hormone replacement. A successful transition from pediatric to adult medicine seems important to optimize treatment outcomes.


Corresponding author: Friederike I.W. Tam, Department of Paediatrics, University Hospital Carl Gustav Carus Dresden, Fetscherstraße 74, 01307 Dresden, Germany, Fax: +49 351 458 5337, E-mail: ; and Faculty of Medicine Carl Gustav Carus, Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany

Acknowledgments

This work was financially supported by Eli Lilly Deutschland GmbH. The authors declare that there is no conflict of interests regarding the publication of this paper.

References

1. Viswanathan V, Eugster EA. Etiology and treatment of hypogonadism in adolescents. Pediatr Clin N Am 2011;58:1181–200.10.1016/j.pcl.2011.07.009Search in Google Scholar

2. Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol 2000;161:73–88.10.1016/S0303-7207(99)00227-0Search in Google Scholar

3. Heinz M. Hormonal development therapy (HDT) in hypogonadism in long-term view. Best Pract Res Cl Ob 2010;24:149–55.10.1016/j.bpobgyn.2009.11.013Search in Google Scholar PubMed

4. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008;358:1474–82.10.1056/NEJMcp0707217Search in Google Scholar PubMed

5. Tuck SP, Francis RM. Testosterone, bone and osteoporosis. Front Horm Res 2009;37:123–32.Search in Google Scholar

6. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009;30:10–22.10.2164/jandrol.108.005215Search in Google Scholar PubMed

7. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocr Metab 2003;88:2404–11.10.1210/jc.2003-030242Search in Google Scholar PubMed

8. Pedreira CC, Hameed R, Kanumakala S, Zacharin M. Health-care problems of Turner syndrome in the adult woman: a cross sectional study of a Victorian cohort and a case for transition. Intern Med J 2006;36:54–7.10.1111/j.1445-5994.2005.00990.xSearch in Google Scholar PubMed

9. Bondy C, Bakalov VK, Lange ED, Ceniceros I. Deficient medical care for adults with the Turner syndrome. Ann Intern Med 2006;145:866–7.10.7326/0003-4819-145-11-200612050-00020Search in Google Scholar PubMed

10. Davies MC. Lost in transition: the needs of adolescents with Turner syndrome. BJOG 2010;117:134–6.10.1111/j.1471-0528.2009.02410.xSearch in Google Scholar PubMed

11. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 2008;43:1115–21.10.1016/j.bone.2008.08.106Search in Google Scholar PubMed

12. World Health Organization. Obesity: preventing and managing the global epidemic, World Health Organ Tech Rep Ser 894. Geneva: World Health Organization, 2000:1–253.Search in Google Scholar

13. Mensink GB, Lampert T, Bergmann E. Übergewicht und Adipositas in Deutschland 1984–2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005;48:1348–56.10.1007/s00103-005-1163-xSearch in Google Scholar PubMed

14. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5.10.1161/CIRCULATIONAHA.109.192644Search in Google Scholar PubMed

15. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, et al. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 2007;6:22–31.10.1186/1475-2840-6-22Search in Google Scholar PubMed PubMed Central

16. Bullinger M, Kirchberger I. SF-36: Fragebogen zum Gesundheitszustand, Handanweisung. Göttingen: Hogrefe, 1998.Search in Google Scholar

17. Viner R. Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 1999;81:271–5.10.1136/adc.81.3.271Search in Google Scholar PubMed PubMed Central

18. Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002;81:603–11.10.1034/j.1600-0412.2002.810705.xSearch in Google Scholar PubMed

19. Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner’s syndrome. Clin Endocrinol 1998;49: 447–50.10.1046/j.1365-2265.1998.00552.xSearch in Google Scholar PubMed

20. Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocr Metab 2002;87:599–603.10.1210/jcem.87.2.8299Search in Google Scholar PubMed

21. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, et al. The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 2006;29:1591–8.10.2337/dc06-0145Search in Google Scholar PubMed

22. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syndrome in adulthood. Endocr Rev 2002;23:120–40.Search in Google Scholar

23. Giordano R, Forno D, Lanfranco F, Manieri C, Ghizzoni L, et al. Metabolic and cardiovascular outcomes in a group of adult patients with Turner’s syndrome under hormonal replacement therapy. Eur J Endocrinol 2011;164:819–26.10.1530/EJE-11-0002Search in Google Scholar PubMed

24. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115:3318–25.10.1172/JCI27071Search in Google Scholar PubMed PubMed Central

25. Popat VB, Calis KA, Vanderhoof VH, Cizza G, Reynolds JC, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009;94:2277–83.10.1210/jc.2008-1878Search in Google Scholar

26. Bakalov VK, Chen ML, Baron J, Hanton LB, Reynolds JC, et al. Bone mineral density and fractures in Turner syndrome. Am J Med 2003;115:259–64.10.1016/S0002-9343(03)00364-4Search in Google Scholar

27. Bannink EM, Raat H, Mulder PG, de Muinck Keizer-Schrama SM. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. J Pediatr 2006; 148:95–101.10.1016/j.jpeds.2005.08.043Search in Google Scholar PubMed

28. Boman UW, Bryman I, Halling K, Möller A. Women with Turner syndrome: psychological well-being, self-rated health and social life. J Psychosom Obstet Gynecol 2001;22:113–22.10.3109/01674820109049961Search in Google Scholar PubMed

29. Ros C, Alobid I, Balasch J, Mullol J, Castelo-Branco C. Turner’s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. Am J Obstet Gynecol 2013;208:484e1–6.10.1016/j.ajog.2013.01.011Search in Google Scholar PubMed

30. Næss EE, Bahr D, Gravholt CH. Health status in women with Turner syndrome: a questionnaire study on health status, education, work participation and aspects of sexual functioning. Clin Endocrinol 2010;72:678–84.10.1111/j.1365-2265.2009.03715.xSearch in Google Scholar PubMed

31. Herlihy AS, McLachlan RI, Gillam L, Cock ML, Collins V, et al. The psychosocial impact of Klinefelter syndrome and factors influencing quality of life. Genet Med 2011;13:632–42.10.1097/GIM.0b013e3182136d19Search in Google Scholar PubMed

32. Tyler C, Edman JC. Down syndrome, Turner syndrome, and Klinefelter syndrome: primary care throughout the life span. Prim Care 2004;31:627–48.10.1016/j.pop.2004.04.006Search in Google Scholar PubMed

33. Poretti A, Grotzer MA, Ribi K, Schönle E, Boltshauser E, et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 2004;46:220–9.10.1111/j.1469-8749.2004.tb00476.xSearch in Google Scholar

34. Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 2011;165:17–24.10.1530/EJE-11-0158Search in Google Scholar PubMed

Received: 2015-1-7
Accepted: 2015-2-26
Published Online: 2015-4-18
Published in Print: 2015-9-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Growth hormone
  3. Growth hormone and growth hormone deficiency – still a lot to learn
  4. Dynamic changes in the hypothalamic- pituitary-adrenal axis during growth hormone therapy in children with growth hormone deficiency: a multicenter retrospective study
  5. Pituitary gland size is a useful marker in diagnosing isolated growth hormone deficiency in short children
  6. Carotid intima-media thickness in children treated with growth hormone
  7. The c.301_302delAG PROP1 gene mutation in Romanian patients with multiple pituitary hormone deficiency
  8. Growth impairment and growth hormone-IGF-1 axis in infantile anorexia nervosa
  9. Growth hormone deficiency in a patient with mitochondrial disease
  10. Perrault syndrome with growth hormone deficiency: a rare autosomal recessive disorder
  11. Review articles
  12. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets
  13. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development
  14. Original articles
  15. Carotid intimal medial thickness and its relation to endothelial dysfunction and echocardiographic changes in adolescents with type 1 diabetes
  16. Insulin dynamics and biochemical markers for predicting impaired glucose tolerance in obese Thai youth
  17. Effects of adolescence-onset hypogonadism on metabolism, bone mineral density and quality of life in adulthood
  18. Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study
  19. Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial
  20. Protein-induced hyperinsulinaemic hypoglycaemia due to a homozygous HADH mutation in three siblings of a Saudi family
  21. Waist-to-height ratio as a screening measure for identifying adolescents with hypertriglyceridemic waist phenotype
  22. Assessment and relation of total and regional fat mass with bone mineral content among Indian urban adolescents
  23. Evaluation of the relationship between serum adropin levels and blood pressure in obese children
  24. Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function
  25. Response of vitamin D binding protein and free vitamin D concentrations to vitamin D supplementation in hospitalized premature infants
  26. Can school health check-ups serve as screening tool for growth anomalies and obesity in children?
  27. The spectrum of 46XY disorders of sex development in a University centre in Saudi Arabia
  28. Clinical and molecular characterization of five Spanish kindreds with X-linked adrenal hypoplasia congenita: atypical findings and a novel mutation in NR0B1
  29. Clinical characteristics of children referred for signs of early puberty before age 3
  30. Effects of GnRH analogue treatment on anterior pituitary hormones in children with central precocious puberty
  31. Anti-Müllerian hormone in children: a ten-year prospective longitudinal study (EarlyBird 39)
  32. Patient reports
  33. A rare cause of fatal pulmonary alveolar proteinosis: Niemann-Pick disease type C2 and a novel mutation
  34. Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves’ disease
  35. Dyshormonogenesis seems to be more frequent in a group of Cameroonian children with congenital hypothyroidism
  36. Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up
  37. Cerebral infarction and femoral venous thrombosis detected in a patient with diabetic ketoacidosis and heterozygous factor V Leiden G1691A and PAI-1 4G/5G mutations
  38. Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency
  39. Short communication
  40. Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
  41. Letters to the Editor
  42. Psychiatric disorders are associated with increased risk for developing hyponatraemia in children
  43. Rett syndrome and precocious puberty association
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0005/html
Scroll to top button